KCNJ10 and ischemic stroke: Notably, in a transient middle cerebral artery occlusion (tMCAO) mouse model, Kir4.1 channel deficits in NG2-glia cause axonal myelin loss, thus unraveling a potential therapeutic target in the treatment of ischemic stroke.